Endocrine disruptive effects of cadmium on steroidogenesis: human adrenocortical carcinoma cell line NCI-H295R as a cellular model for reproductive toxicity testing.
Cadmium (Cd) is a known endocrine disruptor with the ability to affect the production of hormones involved in the regulation of reproductive processes. In this study human adrenocortical carcinoma cell line NCI-H295R was used as an in vitro biological model to study the effect of cadmium (CdCl2) on steroidogenesis. The cell cultures were exposed to different concentrations of CdCl2 (1.90, 3.90, 7.80, 15.60, 31.20 and 62.50 μM) and compared to control (medium without CdCl2). Cell viability was measured by the metabolic activity (MTT) assay for estimation of mitochondria structural integrity. Quantification of sexual steroid production directly from aliquots of the medium was performed by enzyme linked immunosorbent assay (ELISA). Following 48 h culture of the cells in the presence of CdCl2 a concentration-dependent depletion in progesterone production was observed at the lower concentrations of CdCl2. The lowest amount of progesterone was significantly detected in groups with the higher doses (≥ 31.20 μM) of CdCl2, which elicited significant (P < 0.01) cytotoxic action, too. Cadmium decreased testosterone release in the whole applied range even at the lower concentration of CdCl2. The release of 17β-estradiol decreased as well, but the decline was less pronounced compared to decrease of progesterone and testosterone. The cytotoxic effect was significantly (P < 0.01) detected at all concentrations of CdCl2 (1.90-62.50 μM) used in the study. However, the cell viability remained relatively high (>75%) up to 7.80 μM of CdCl2 and significantly (P < 0.01) decreased at 15.60 μM and higher concentrations of CdCl2. These results suggest that cadmium has endocrine disruptive effects on sexual steroid synthesis even at very low concentrations.
a Department of Animal Physiology , Slovak University of Agriculture , Nitra , Slovak Republic.
Zuzana
Z
Knazicka
Zsolt
Z
Forgacs
Jana
J
Lukacova
Shubhadeep
S
Roychoudhury
Peter
P
Massanyi
Norbert
N
Lukac
D000306:Adrenal Cortex Neoplasms / Q000378:metabolism / Q000473:pathology; D018268:Adrenocortical Carcinoma / Q000378:metabolism / Q000473:pathology; D019256:Cadmium Chloride / Q000633:toxicity*; D045744:Cell Line, Tumor / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D052244:Endocrine Disruptors / Q000633:toxicity*; D004797:Enzyme-Linked Immunosorbent Assay; D004958:Estradiol / Q000096:biosynthesis*; D006801:Humans; D011374:Progesterone / Q000096:biosynthesis*; D013739:Testosterone / Q000096:biosynthesis*; D018675:Toxicity Tests / Q000379:methods*
D052244:Endocrine Disruptors; D013739:Testosterone; D011374:Progesterone; D004958:Estradiol; D019256:Cadmium Chloride
Cadmium chloride; NCI-H295R cell line steroid hormones; cell viability; endocrine disruption